Variable | Number (%) |
---|---|
Salbutamol puff PRN + Beclomethasone puff Bid | 313 (76.5%) |
Salbutamol puff PRN + Prednisolone oral daily | 25 (6.1%) |
Salbutamol puff PRN + Beclomethasone puff Bid + Prednisolone | 47 (11.5%) |
Salbutamol puff PRN + Beclomethasone puff Bid+ theophylline daily | 6 (1.5%) |
Salbutamol puff PRN + Budesonide puff bid | 4 (1%) |
Theophylline +Salbutamol puff PRN | 4 (1%) |
Theophylline +Salbutamol puff PRN + prednisolone daily | 1 (.2%) |
Fluticasone puff +Salbutamol puff PRN | 2 (0.5%) |
Beclomethasone puff bid+ salbutamol puff PRN + symicort | 2 (.5%) |
Alimetamin | 3 (.7%) |
Oral SABA +salbutamol puff | 2 (0.5%) |
Medication adherent | |
 High | 57 (13.9%) |
 Low | 352 (86.1%) |
Dose of the anti-asthmatic drug | |
 Optimal | 305 (74.6%) |
 Suboptimal | 104 (25.4%) |
Appropriateness of drug selection based on severity | |
 Appropriate | 291 (71.1%) |
 Inappropriate | 118 (28.8%) |
Healthcare providers adherence to guidelines | |
 Yes | 320 (78.2%) |
 No | 89 (21.8%) |
Patient information provided | |
 Yes | 304 (74.3%) |
 No | 105 (25.7%) |
Patient relationship with healthcare provider | |
 Good | 375 (91.7%) |
 Poor | 34 (8.3%) |